| INTRODUCTION
The production of thyroid hormones is controlled by thyroidstimulating hormone (TSH) produced by anterior pituitary gland.
Human chorionic gonadotropin (HCG) produced by placenta also directly stimulates thyroid hormones production. TSH production is regulated by negative feedback of free thyroid hormones.
Pregnancy has a significant impact on the thyroid gland function.
Production of the thyroid hormones, thyroxine (T4), and triiodothyronine (T3) increases by nearly 50%, in conjunction with a separate 50% increase in the daily iodine requirement. 1 Thyroid hormones have a key role in embryo and fetus development. The lack of maternal thyroid hormones in pregnancy is associated with serious maternal, fetal, and newborn complications: spontaneous abortions, preterm birth, preeclampsia, gestational diabetes, induction, cesarean section, intensive care unit admission, placental abruption, and breech presentation. Screening for thyroid dysfunction should be applied in all high-risk women-and, according to some authorities-in all women in early pregnancy. 2 Today, 70% of objective information on patients is based on laboratory test results. Valid reference ranges and/or cut-off points of any laboratory test results are needed for further clinical decision making. 3 Manufacturers usually provide only reference ranges for general population but these reference ranges cannot be applied in early pregnancy because high maternal plasma HCG levels cause increase in 
R E S E A R C H A R T I C L E
Maternal thyroid-stimulating hormone reference ranges for first trimester screening from 11 to 14 weeks of gestation 
Conclusions:
Each first trimester screening center should be aware of which type of immunoassay their laboratory uses. TSH reference ranges in women during the first trimester of pregnancy are lower than those for general population. Twin pregnancies have lower TSH than singleton pregnancies.
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gestation, immunoassay, pregnancy, reference interval, thyroid disease plasma level of thyroid hormones and subsequently, due to negative feedback, decrease in TSH production.
Moreover, different immunoassays yield different results. It is vis-
ible in external quality proficiency testing results. Certainly, no two methods are exactly the same; the issue is whether the difference is important relative to the clinical question. 4 That is why we decided to establish reference ranges of TSH in the period of first trimester Down's syndrome screening, that is from 11 to 13 + 6 weeks of gestation.
| MATERIALS AND METHODS

| Subjects
Reference ranges were established from 12 278 consecutive patients who underwent prenatal first trimester Down's syndrome screening together with thyroid function screening at the Department of ob- Adequate iodine intake was assumed because iodized salt has been distributed in the Czech Republic since 1947. 5 The study was approved by the hospital Ethics committee in Zlín, Czech Republic and performed according to Declaration of Helsinki.
| Methods
Fasting venous blood samples were obtained in the morning. VACUETTE ® red top 6 mL tubes (Greiner Bio-One GmbH, Kremsmünster, Austria) with clot activator and without gel separator were used for venous blood collection. The separation of cells from serum was performed within 45 minutes.
TSH, TPOAb, freeT4 were measured by immunochemiluminescent assay on ci 16200 Abbott Architect analyzer (Abbott Laboratories,100
Abbott Park Road, Abbott Park, Illinois 60064-3500, USA).
Manufacturer-recommended reference range for general population is 0.35-4.94 mU/L.
| Statistical analysis
MedCalc statistical software version 17.4 (MedCalc Software bvba, Ostend, Belgium) was used for statistical analysis. D'Agostino-Pearson test was used for normal distribution testing.
We used International Federation of Clinical Chemistry and
Laboratory Medicine (IFCC) recommended nonparametric percentile method (also known as CLSI C28.A3) for the determination of reference ranges. 6 Lower reference limit is defined as 2.5th percentile and upper ref- 
| RESULTS
The median (IQR) of gestation age of singleton pregnancies was 12 weeks + 4 days (12 + 2-13 + 0). The median (IQR) of gestation age of twin pregnancies was 12 weeks +5 days (12 + 3-13 + 1). The results of TSH in both types of pregnancies did not have normal distribution (P < .0001). Both skewness and kurtosis were present. For singleton pregnancies, coefficient of skewness was 1.02 (P < .0001) and coefficient of kurtosis 1.39 (P < .0001). For twin pregnancies, coefficient of skewness was 1.30 (P < .0001) and coefficient of kurtosis 2.44 (P = .0001). Figures 1 and 2 show the positively skewed distribution of TSH values for both singleton and twin pregnancies. The reference ranges (90% CI) for singleton and twin pregnancies are presented in Table 1 .
The median (IQR) of TSH for singleton pregnancies was higher than that for twin pregnancies (1.25 mU/L (0.83-1.81) vs 0.84 (0.37-1.47), respectively; P < .0001).
| DISCUSSION
We determined reference ranges for TSH for singleton and twin pregnancies in Caucasian ethnic group. We performed TSH test Its recommendation 29 states that L-thyroxine therapy is recommended for TPOAb-positive women with TSH greater than the pregnancy-specific reference range. 1 We created reference ranges according to this approach.
First trimester thyroid function testing may impact prediction of Down's syndrome risk. When screening simultaneously for maternal thyroid disease and Down's syndrome, thyroid marker levels should be used in the calculation of Down's syndrome risk. The benefit is modest but can be achieved with no additional cost. 11 The major limitations of this study are that we did not perform ultrasonography of the thyroid gland, and we had low number of other ethnic group patients for establishment of reference ranges.
In summary, each first trimester screening center should be aware of which type of immunoassay their laboratory uses. TSH reference ranges in women during the first trimester of pregnancy are lower than those for general population. We established reference ranges of TSH for the period of gestation from 11 + 0 to 13 + 6 weeks of pregnancy CI, confidence interval.
